drugset / Trial / NCT00916045

Pilot Study of Unrelated Cord Blood Transplantation

NCT00916045 ↗

Phase 2 Terminated 40 enrolled King's College Hospital NHS Trust
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the safety and feasibility of unrelated double and single cord blood transplantation in patients with haematological malignancies using reduced-intensity or myeloablative conditioning regimens.

Timeline

Start
2009-09
Primary completion
2012-03
Completion
2012-03

Outcome

Outcome not reported

Stopped (Enrollment): “Recruitment issues”

Drugs

EvaluationDrugModalityDoseRoute
Subject Cyclophosphamide Other / unclassified — —
Subject Melphalan Small molecule — —
Subject Thiotepa Other / unclassified — —
Background Busulphan Unknown — Intravenous
Background Cyclosporine Peptide — —
Background Fludarabine Small molecule — —
Background Mycophenolate Mofetil Small molecule — —
Background Thymoglobulin Protein / enzyme biologic — —